BELLUS Health Reports Year 2021 Financial Results and Business Highlights
- Announced positive topline results from the Phase 2b SOOTHE clinical trial in refractory chronic cough ("RCC"), positioning BLU-5937 as a potentially best-in-class P2X3 antagonist - - Plans to requ...